PPARA and breast cancer: PPARα activation increases proliferation in breast cancer cell lines and in renal cell carcinoma cell line [24-25] and causes liver cancer in rodents, while PPARα null-mice are shown to be resistant to hepatocarcinogenic effects of PPARα agonists [26].